Revenues

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Revenues [Text Block]

15. Revenues

The following table presents our revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenues:

		December 31, 2021		December 31, 2020
Research and development agreements	$	699	$	562
Product revenue		267		-
Sales milestone revenue		320		-
Licensing agreements		249		982
	$	1,535	$	1,544

The following table presents our revenues disaggregated by timing of recognition:

		December 31, 2021		December 31, 2020
Product and services transferred at point in time	$	836	$	1,185
Products and services transferred over time		699		359
	$	1,535	$	1,544

The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers:

		December 31, 2021		December 31, 2020
Europe	$	1,023		795
Canada		263		708
United States		249		41
	$	1,535	$	1,544

Remaining performance obligations

As at December 31, 2021, the aggregate amount of the transaction price allocated to the remaining performance obligation is $1,816 representing research and development agreements, the majority of which is expected to be recognized in the next twelve months. The Company is also eligible to receive up to $2,558 in research and development milestone payments, approximately 100% of which is expected to be recognized in the next three years; up to $433 in commercial sales milestone payments which are wholly dependent on the marketing efforts of our development partners. In addition, the Company is entitled to receive royalties on potential sales.

The Company applies the practical expedient in paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have original expected durations of one year or less.